Aquestive Therapeutics, Inc. (AQST) — 10-Q Filings
All 10-Q filings from Aquestive Therapeutics, Inc.. Browse 3 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (3)
-
Aquestive's Q2 Loss Widens to $20.2M Amid Rising Costs
— Aug 11, 2025 Risk: high
Aquestive Therapeutics, Inc. reported a net loss of $20.2 million for the three months ended June 30, 2025, a significant increase from the $16.7 million net lo -
Aquestive Therapeutics Q1 2025 10-Q Filed
— May 12, 2025 Risk: medium
Aquestive Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported its financial results for the first quarter of 2025, deta -
Aquestive Therapeutics Files Q3 2024 10-Q
— Nov 4, 2024 Risk: medium
Aquestive Therapeutics, Inc. filed a 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the thi
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX